NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up Status COMPLETED Phase N/A
NCT01195220 Project AWARE: Using the Emergency Department (ED) to Prevent Sexually Transmitted Infections (STIs) in Youth Status WITHDRAWN Phase NA
NCT01191203 Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi Status COMPLETED Phase NA
NCT01190605 Evaluating Factors That Impact Loss to Follow-up Among Postpartum HIV-infected Women in Mississippi Status COMPLETED Phase N/A
NCT01189695 Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure Status COMPLETED Phase PHASE4
NCT01188941 Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa Status COMPLETED Phase NA
NCT01182298 Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection Status TERMINATED Phase N/A
NCT01178684 Epidermal Nerve Fiber Density, Fat and Mitochondrial Parameters in Thai HIV+ Patients on d4T and HIV- Patients Status COMPLETED Phase N/A
NCT01172535 A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines Status COMPLETED Phase PHASE2/PHASE3
NCT01161446 Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study) Status COMPLETED Phase NA
NCT01160575 A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDY Status WITHDRAWN Phase N/A
NCT01160120 Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz Status COMPLETED Phase PHASE2
NCT01158443 Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS Status COMPLETED Phase PHASE4
NCT01153217 Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density Status COMPLETED Phase PHASE3